Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD

被引：0

作者：

Ekroos, Heikki ^{[1
]}

Hahl, Jarmo ^{[2
]}

Tuppurainen, Kaisa ^{[3
]}

Linden, Kari ^{[3
]}

Linna, Miika ^{[4
,5
]}

Sintonen, Harri ^{[6
]}

机构：

[1] Hosp Dist Helsinki & Uusimaa, Porvoo Hosp, Porvoo, Finland

[2] Med Affairs Consulting Medaffcon Oy, Market Access & Hlth Outcomes, Espoo, Finland

[3] Pfizer Oy, Dept Med, Helsinki, Finland

[4] Aalto Univ, Dept Ind Engn & Management, HEMA Inst, Helsinki, Finland

[5] Natl Inst Hlth & Welf, Helsinki, Finland

[6] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland

来源：

关键词：

Smoking; COPD; -; management; Quality of life;

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

2054

引用

页数：1